SARAH IACONA: Open Payments
NPI 1457128506 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,482 in 151 payments from 45 companies in 2025. Trend: 2023 $106 · 2024 $2,617 · 2025 $3,482
Food & beverage: $3,383Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $376 |
| AstraZeneca Pharmaceuticals LP | 13 | $369 |
| Incyte Corporation | 15 | $274 |
| Janssen Biotech, Inc. | 12 | $240 |
| Genentech USA, Inc. | 8 | $184 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $155 |
| Daiichi Sankyo Inc. | 5 | $134 |
| Eisai Inc. | 5 | $127 |
| Merck Sharp & Dohme LLC | 5 | $109 |
| Tempus AI, Inc | 4 | $86 |
Products named: CARVYKTI, KISQALI, Venclexta, JAKAFI, ENHERTU, Lenvima, KEYTRUDA, Nubeqa.
Industry payments across PA — which companies pay providers there.
